middle.news
How Algorae’s AI is Revolutionising Cancer Drug Synergy Testing at Peter Mac
9:06am on Monday 30th of March, 2026 AEDT
•
Healthcare
Read Story
How Algorae’s AI is Revolutionising Cancer Drug Synergy Testing at Peter Mac
9:06am on Monday 30th of March, 2026 AEDT
Key Points
Second AI-driven drug synergy screening program initiated
24 high-priority drug combinations selected for preclinical validation
Testing across glioblastoma, rhabdomyosarcoma, melanoma, and leukemia cell lines
Results expected within six months to support clinical and commercial pathways
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
ALGORAE PHARMACEUTICALS (ASX:1AI)
OPEN ARTICLE